Rachel Burgoon, Pharm.D.

Medical University of South Carolina

Disclosure(s): Merck: Grant/Research Support

Poster(s):

• (P-60) Evaluation of clinical outcomes in Methicillin-Resistant Staphylococcus aureus bacteremia with earlier vs. later initiation of dual antimicrobial salvage therapy
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-1756) Utility and Clinical Impact of Karius Testing in the Adult Population of a Tertiary Care Center: A Retrospective Study
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET

• (P-1916) Donor Dilemma: A Pilot Study of a Novel Curriculum to Address Gaps in Transplant ID Training
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET

• (P-1989) Utility of Karius Testing in High‑Risk Immunocompromised Hosts: A Retrospective Study
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET

• (P-2111) Heart Transplant Candidates and Strongyloides stercoralis: Screening Outcomes and Testing Rates in Solid Organ Transplants
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET